Secondary analysis of the SANO trial (274 patients with oesophageal cancer and complete response after nCRT; 234 responded): at 6 months active surveillance versus surgery gave better dysphagia, dyspnoea, fatigue and physical functioning; dysphagia stayed better at 24 months.
Secondary analysisn = 274
Gangaram Panday et al. Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial)